Novavax has received the green light from the US Food and Drug Administration (FDA) to resume clinical trials for its ...

Neurogene shares tumbled 35% last night after it disclosed that a pediatric patient with Rett syndrome experienced a severe ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...

The recent Phase I data for ORX750, aimed at sleep disorders, showed significant efficacy with a placebo-adjusted improvement ... focusing on stocks such as Cytokinetics, Novavax, and Trevi ...

Positive data for the combinations indicate stronger efficacy than would be expected from chemotherapy ... Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX ...

A new study from the Centers for Disease Control and Prevention (CDC) reveals that fewer than one in six health workers ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that Åsa ...

HG202 is the first CRISPR/Cas13Y RNA-targeting therapy to enter clinical development and the only clinical-stage CRISPR RNA-editing therapy for age-related macular degeneration Preclinical studies in ...

B.Riley Financial analyst Mayank Mamtani maintained a Hold rating on Cognition Therapeutics (CGTX – Research Report) today and set a ...

Would another Pharma or biotech look to develop other vaccine candidates using Novavax's technology? It is not impossible - management's execution, not the underlying efficacy of its protein-based ...